Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGC Pharma

0.2896
+0.00461.61%
Volume:240.77K
Turnover:69.72K
Market Cap:23.08M
PE:-2.39
High:0.2941
Open:0.2900
Low:0.2828
Close:0.2850
Loading ...

Company Profile

Company Name:
IGC Pharma
Exchange:
AMEX
Establishment Date:
2005
Employees:
67
Office Location:
10224 Falls Road,Potomac,Maryland,United States
Zip Code:
20854
Fax:
- -
Introduction:
IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Directors

Name
Position
Ram Mukunda
President, Chief Executive Officer and Director
Richard Prins
Chairman of the Board
Claudia Grimaldi
Vice President, Principal Financial Officer, Chief Compliance Officer and Director
James Moran
Director

Shareholders

Name
Position
Ram Mukunda
President, Chief Executive Officer and Director
Claudia Grimaldi
Vice President, Principal Financial Officer, Chief Compliance Officer and Director